New York, USA – February 21, 2022 – BOC Sciences is perceived as an undisputed global leader in the biochemistry field because of its unprecedented skills. However, that’s not the whole story. Aside from making every effort to product and service optimization, BOC Sciences also sustains fierce social conscience that motivates it to organize a series of academic activities.
The webinar entitled Targeting RNA Structure as a Therapeutic Strategy literally indicates that the subject is in connection with RNA therapies. BOC Sciences invited the distinguished professor Silvia Rouskin from Harvard Medical School to expound her latest findings on RNA structure and the potential to exploit it for therapeutic purposes.
During one hour of the meeting, Dr. Rouskin highlighted the innovative strategies to determine RNA structure in cells, quantify alternative conformations, and target RNA structure. Then the Q&A session was carried out smoothly with several listeners’ questions patiently replied. “This webinar is an academic feast that enlightens me much on my RNA research. I appreciate Dr. Rouskin’s professionalism, as well as BOC Sciences’ dedication to arranging such an informative meeting,” a researcher of chemistry wrote to BOC Sciences.
BOC Sciences, the largest pseudoUridine supplier, has dived into RNA-related research for years. Its pseudoUridines are contrived based on the thorough exploration and substantial knowledge about RNA modification. Currently, the product list contains not only pseudoUridines but also manifold derivatives which are all prevalent among researchers to improve the stability and rigidity of RNA secondary structure. 1-methylpseudoUridine (m1Ψ) is one of the superstars that remarkably increases mRNA expressivity upon transfection and eliminates innate immunogenicity.
Accompanied by advanced facilities and professional personnel, BOC Sciences becomes a competitive chemical and biochemical manufacturer with an annual output of pseudoUridines exceeding 500 kg. This is a reassuring number suggesting that it is competent to deal with massive orders under the pressure of COVID-19. BOC Sciences is always in pursuit of scale-up production, whereas it never gives up strict quality control which is the code of its prosperity.
For anyone who has missed the webinar, or would like to review it, BOC Sciences offers the long-effective access here: https://nucleotech.bocsci.com/webinar-targeting-rna-structure-as-a-therapeutic-strategy.html.
About
BOC Sciences is a world-leading drug discovery supporter, providing qualified phosphoramidite pseudoUridine and its derivatives. By virtue of the cutting-edge equipment and expertise, it gradually increases pseudoUridine production to 500 kg per year, winning first place in the industry.
Media ContactCompany Name: BOC SciencesContact Person: Alex BrownEmail: Send EmailPhone: 1-631-485-4226Country: United StatesWebsite: https://nucleotech.bocsci.com
